Platelet-rich Plasma (PRP) Injection for Treatment of Erectile Function

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

September 2, 2019

Primary Completion Date

March 26, 2020

Study Completion Date

September 24, 2020

Conditions
Erectile Dysfunction Due to Arterial Insufficiency
Interventions
BIOLOGICAL

Platelet-Rich Plasma (PRP)

All subjects of this group will receive 2 sessions of PRP penile injection with 30 +/- 3 day treatment interval, 10 ml of PRP will be injected at each session.

BIOLOGICAL

Normal saline injection

All subjects of this group will receive 2 sessions of normal saline penile injection with 30 +/- 3 day treatment interval for all subjects, 10 ml of normal saline will be injected at each session.

Trial Locations (1)

54621

G.Gennimatas Hospital, Thessaloniki

All Listed Sponsors
collaborator

European Society for Sexual Medicine

UNKNOWN

lead

Institute for the Study of Urological Diseases, Greece

OTHER

NCT04050020 - Platelet-rich Plasma (PRP) Injection for Treatment of Erectile Function | Biotech Hunter | Biotech Hunter